Prophylaxis of bipolar disorder: how and who should we treat in the long term? (Q33753321)

29 July 2017

1 reference

title

Prophylaxis of bipolar disorder: how and who should we treat in the long term? (English)

1 reference

29 July 2017

1 reference

Goodwin GM

1

1 reference

PubMed ID

10524839

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

European Neuropsychopharmacology

29 July 2017

1 reference

29 July 2017

9 Suppl 4

1 reference

29 July 2017

S125-9

1 reference

The syndrome of irreversible lithium-effectuated neurotoxicity (SILENT).

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Lamotrigine and the treatment of mania in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Lamotrigine in the treatment of bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Clinical studies on the use of lamotrigine in bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Lithium: balancing risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Lithium use and discontinuation in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

An open study of lamotrigine in refractory bipolar depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Carbamazepine vs lithium in the treatment and prophylaxis of mania

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Is there a lithium withdrawal syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Rapid recurrence of mania following abrupt discontinuation of lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Trials: the next 50 years. Large scale randomised evidence of moderate benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Large-scale randomized evidence: large, simple trials and overviews of trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

The treatment of manic psychoses by the administration of lithium salts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Efficacy of lithium as acute treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Effect of lithium maintenance on suicidal behavior in major mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

Differential Treatment of Bipolar Disorder with Old and New Antiepileptic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900026-7

7 January 2021

10.1016/S0924-977X(99)00026-7

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10524839